# Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis

> **NCT00396643** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 81 (actual)

## Conditions studied

- Schizophrenia
- Prodrome

## Interventions

- **DRUG:** Omega 3 fatty acids

## Key facts

- **NCT ID:** NCT00396643
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2007-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396643, "Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00396643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*